Universal-Beteiligungs- und Servicegesellschaft
VRTX icon

Universal-Beteiligungs- und Servicegesellschaft’s Vertex Pharmaceuticals VRTX Stock Holding History

Universal-Beteiligungs- und Servicegesellschaft’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$161M Sell
323,752
-14,595
-4% -$6.47M 0.25% 77
2026
Q1 		$151M Buy
338,347
+3,449
+1% +$1.61M 0.26% 73
2025
Q4 		$152M Buy
334,898
+15,431
+5% +$6.65M 0.25% 77
2025
Q3 		$125M Buy
319,467
+5,786
+2% +$2.42M 0.21% 94
2025
Q2 		$140M Buy
313,681
+7,220
+2% +$3.33M 0.25% 78
2025
Q1 		$149M Sell
306,461
-33,047
-10% -$15.4M 0.3% 63
2024
Q4 		$137M Buy
+339,508
New +$157M 0.27% 71

Other funds holding VRTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Amundi
Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft's VRTX Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft reduced its Vertex Pharmaceuticals (VRTX) stake by 4.3% in Q2 2026, selling an estimated $6.47M and leaving 323,752 shares worth $161M. The position accounts for 0.25% of the portfolio, ranked #77.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in VRTX in Q4 2024 and has held it in 7 quarters since. 1,190 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Universal-Beteiligungs- und Servicegesellschaft held 323,752 shares of Vertex Pharmaceuticals worth $161M as of Q2 2026.
  • Universal-Beteiligungs- und Servicegesellschaft sold 14,595 Vertex Pharmaceuticals shares in Q2 2026, an estimated $6.47M.
  • Vertex Pharmaceuticals made up 0.25% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #77 holding.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in Vertex Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • 1,190 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.